ACM
FBIO icon

Advent Capital Management’s Fortress Biotech FBIO Stock Holding History

Advent Capital Management’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-5,951
Closed -$187K – 480
2014
Q3 		$187K Sell
5,951
-449
-7% -$11.9K ﹤0.01% 437
2014
Q2 		$187K Sell
6,400
-9,667
-60% -$255K ﹤0.01% 434
2014
Q1 		$477K Buy
+16,067
New +$627K 0.01% 411
2013
Q4 		– Sell
-13,460
Closed -$520K – 531
2013
Q3 		$1.42M Buy
13,460
+11,460
+573% +$1.41M 0.02% 425
2013
Q2 		$258K Buy
+2,000
New +$295K ﹤0.01% 510

Other funds holding FBIO

EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Advent Capital Management's FBIO Position: Q4 2014 in Review

Advent Capital Management sold out of Fortress Biotech (FBIO) in Q4 2014, closing a stake of 5,951 shares — an estimated $187K sold.

Advent Capital Management first reported a position in FBIO in Q2 2013 and held it in 5 quarters. The position peaked at $1.42M in Q3 2013. 36 funds tracked by Wall St. Rank hold FBIO as of Q4 2014.

  • Advent Capital Management reported no remaining Fortress Biotech position as of Q4 2014 after selling out during the quarter.
  • Advent Capital Management sold 5,951 Fortress Biotech shares in Q4 2014, an estimated $187K.
  • Advent Capital Management first reported a position in Fortress Biotech in Q2 2013 and held it in 5 quarters.
  • Advent Capital Management's Fortress Biotech position peaked at $1.42M in Q3 2013.
  • 36 funds tracked by Wall St. Rank held Fortress Biotech as of Q4 2014.

Based on Advent Capital Management's 13F filing for Q4 2014, filed 26 Feb 2015.